BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28440981)

  • 21. A retrospective analysis of complications observed in children with acute lymphoblastic leukemia during chemotherapy.
    Canbolat Ayhan A; Timur C; Kalaycik O
    Minerva Pediatr; 2017 Apr; 69(2):95-105. PubMed ID: 26200521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with a prolonged hospital stay during induction chemotherapy in newly diagnosed high risk pediatric acute lymphoblastic leukemia.
    Warrick K; Althouse SK; Rahrig A; Rupenthal J; Batra S
    Leuk Res; 2018 Aug; 71():36-42. PubMed ID: 30005182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in Mexico.
    Vázquez-Cornejo E; Morales-Ríos O; Juárez-Villegas LE; Islas Ortega EJ; Vázquez-Estupiñán F; Garduño-Espinosa J
    Cancer Med; 2019 Oct; 8(13):5979-5987. PubMed ID: 31445000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
    Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
    J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.
    Suarez A; Piña M; Nichols-Vinueza DX; Lopera J; Rengifo L; Mesa M; Cardenas M; Morrissey L; Veintemilla G; Vizcaino M; Del Toro L; Vicuna V; Fernandez J; Neuberg D; Stevenson K; Gutierrez A
    Pediatr Blood Cancer; 2015 Aug; 62(8):1395-402. PubMed ID: 25808195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of modified St Jude total therapy 13A for childhood acute lymphoblastic leukemia in the southeast region of Turkey.
    Koc A; Aycicek A; Ozdemir ZC; Soker M; Varma M
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):36-41. PubMed ID: 23138117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effectiveness of CCLG-97 protocol on standard-risk childhood acute lymphoblastic leukemia].
    Xiao PF; Chai YH; Li JQ; He HL; Wang Y; Li ZP; He YX; Ji ZH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):486-9. PubMed ID: 16083544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-Hospital Management Might Reduce Induction Deaths in Pediatric Patients With Acute Lymphoblastic Leukemia: Results From a Japanese Cohort.
    Nakagawa S; Kato M; Imamura T; Imai C; Koh K; Kawano Y; Shimomura Y; Watanabe A; Kikuta A; Saito A; Horibe K; Manabe A; Ohara A; Okamoto Y
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):39-46. PubMed ID: 32852400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
    Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
    Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG-ALL-2015.
    Zhu Y; Yang R; Cai J; Yu J; Tang Y; Chen Y; Wang N; He H; Wu X; Cheng FWT; Sun L; He Y; Ju X; Tian X; Hu Q; Jin R; Pan K; Fang Y; Zhai X; Jiang H; Li CK
    Cancer Med; 2020 Mar; 9(6):2113-2121. PubMed ID: 31994344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon.
    Muwakkit S; Al-Aridi C; Samra A; Saab R; Mahfouz RA; Farra C; Jeha S; Abboud MR
    Am J Hematol; 2012 Jul; 87(7):678-83. PubMed ID: 22565284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
    Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
    JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
    Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
    J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
    Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
    Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America.
    Gupta S; Antillon FA; Bonilla M; Fu L; Howard SC; Ribeiro RC; Sung L
    Cancer; 2011 Oct; 117(20):4788-95. PubMed ID: 21446043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Huangqi injection on short-term prognosis in children with acute lymphoblastic leukemia].
    Yan PH; Yan M; Wang XM; Wang SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):141-6. PubMed ID: 24568906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening.
    Berrueco R; Alonso-Saladrigues A; Martorell-Sampol L; Català-Temprano A; Ruiz-Llobet A; Toll T; Torrebadell M; Naudó M; Camós M; Rives S
    Pediatr Blood Cancer; 2015 Jul; 62(7):1195-201. PubMed ID: 25855413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.
    Jaime-Pérez JC; Jiménez-Castillo RA; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Marfil-Rivera LJ; Gómez-Almaguer D
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.